AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Nicotine Patch Plus Nicotine Mouth Spray Versus Nicotine Reduction for Vaping Cessation

RecruitingPhase 3Ages 16 Years - anyAllUniversity of Auckland, New Zealand
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

This research focuses on maximizing the chances of successfully quitting vaping. A large, pragmatic community-based clinical trial is planned in New Zealand to build on existing evidence from previous vaping and smoking cessation research undertaken by the study team. The effectiveness of combination nicotine replacement therapy (NRT) compared to nicotine tapering on vaping abstinence has not yet been investigated, but both provide an opportunity to increase success with vaping cessation, especially when combined with written behavioural support to further boost quit rates. The planned trial will test whether using combination NRT will help more New Zealanders to quit vaping long-term, compared with a vape nicotine tapering plan. Participants in both groups will also receive written vaping cessation behavioural support.

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Live in New Zealand. * Vape nicotine at least weekly (one or more days out of the past seven days). * Used to smoke (i.e. they have smoked tobacco regularly but not at all in the past six months) or have never smoked (i.e., they have never been a regular user of smoked tobacco, defined as less than 100 cigarettes in their lifetime). * Are aged โ‰ฅ16 years. * Are motivated to quit vaping in the next eight weeks. * Are able to provide consent. * Have access to the internet via a computer or smart phone. * Are a registered patient at a New Zealand medical facility. Exclusion Criteria: * They have another person in their household currently enrolled in the study. * They smoke tobacco currently or were a recent regular user of tobacco. * They are enrolled in another vaping cessation programme/trial. * They self-report having had a serious cardiovascular event, or hospitalisation for a cardiovascular complaint, in the previous four weeks (e.g. stroke, myocardial infarction, unstable angina, cardiac arrhythmia, coronary artery bypass graft and angioplasty). * They self-report uncontrolled hypertension. * They have a strong preference to use/not use NRT or nicotine tapering. * They are current users of smoking cessation pharmacotherapy (e.g. NRT, varenicline, cytisine, nortriptyline \[including if it is used for a different indication\], and amitriptyline \[as it converts to nortriptyline\]. * They are currently enrolled in another vaping cessation programme/trial.
๐Ÿ’Š

What it tests

  • Nicotine patches plus nicotine mouth spray
  • Nicotine Tapering Plan
๐Ÿ“

Where

1 site
School of Population Health, Faculty of Medical and Health Sciences, University of Auckland
Auckland, New Zealand
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy